CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

EQT Life Sciences participates in Vaderis Therapeutics' USD 152 million Series B financing

Phase 3engasertib
Related Companies

Read the original article

Published by PR Newswire Biotech on August 11, 2026 11:54 AM

Read Original